Mira Pharmaceuticals (MIRA) Profit After Tax (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Profit After Tax of -$5.9 million for Q4 2025, down 422.19% sequentially from -$1.1 million in Q3 2025, and down 147.57% YoY from $12.5 million in Q4 2024.
Mira Pharmaceuticals (MIRA) Profit After Tax (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Profit After Tax data on file, last reported at -$5.9 million in Q4 2025.
- Quarterly Profit After Tax fell 147.57% year-over-year to -$5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$10.4 million (down 32.44% YoY) and the FY2025 annual result came in at -$10.4 million, down 32.44% from the prior year.
- Profit After Tax slipped to -$5.9 million in Q4 2025 per MIRA's latest filing, from -$1.1 million in the prior quarter.
- The five-year high for Profit After Tax was -$1.1 million in Q3 2025, with the low at -$5.9 million in Q4 2025.
- Average Profit After Tax over 4 years is -$2.4 million, with a median of -$1.8 million recorded in 2024.
- Year-over-year, Profit After Tax sank 328.86% in 2023 and jumped 58.54% in 2024.
- Mira Pharmaceuticals' Profit After Tax stood at -$1.3 million in 2022, then plunged by 328.86% to -$5.8 million in 2023, then jumped by 58.54% to -$2.4 million in 2024, then plunged by 147.57% to -$5.9 million in 2025.
- Business Quant data shows MIRA's Profit After Tax at -$5.9 million in Q4 2025, -$1.1 million in Q3 2025, and -$1.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 7.40 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 5.24 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 697.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 3.08 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -4.24 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.82 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.02 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.71 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | -5.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.94 Mn |
| Sep 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Mar 31, 2025 | -1.78 Mn |
| Dec 31, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -5.79 Mn |
| Sep 30, 2023 | -3.59 Mn |
| Jun 30, 2023 | -1.27 Mn |
| Mar 31, 2023 | -1.34 Mn |
| Dec 31, 2022 | -1.35 Mn |
| Sep 30, 2022 | -1.81 Mn |